Abstract:Background SCN8A mutations have recently been associated with epilepsy and neurodevelopmental disorders. This study aimed to broaden the phenotypic-spectrum of disease related with SCN8A mutations. Methods To identify the pathogenic gene of a Chinese family, in which six members suffered from epilepsy, whole-exome sequencing was performed. In addition, target next-generation sequencing (NGS) was performed on 178 sporadic patients, who had epilepsy of unknown etiology within 6 months after birth. A detailed clinical history was obtained. Results A heterozygous missense mutation of SCN8A was identified in the Chinese family. Six de novo mutations of SCN8A were detected in 6 sporadic patients with epilepsy. In the family, six members developed seizures within a few years after birth. Five of them had milder clinical performance, that they had normal cognition and developmental milestones, and seizure-free was achieved by mono-therapy. The other one affected member presented with refractory epilepsy and developmental regression. She died from sudden unexpected death in epilepsy (SUDEP) at 17-year-old. Clinical features of six sporadic patients with SCN8A mutations were diverse, ranging from severe epileptic encephalopathy to benign epilepsy with normal cognition. Seizures started at the mean age of 3.9 months (from 2 months to 6 months). Seizure-free was achieved in four of them by mono- or multi-antiepileptic drugs. Five of them demonstrated mild or severe psychomotor retardation, whereas the other one was normal in development and intelligence. Conclusions Our findings extend the spectrum of SCN8A mutations and the clinical features of patients with SCN8A mutations. The majority of SCN8A mutations were de novo, inherited mutations from the heterozygous parents can also occur. The phenotypic spectrum of SCN8A mutation varied largely. Most affected patients manifested as refractory epilepsy and severe intellectual disability, only a small number of patients presented with milder clinical patterns. Additionally, our study confirmed that the same mutation can lead to different phenotypes.

De Novo and Inherited SETD1A Variants in Early-onset Epilepsy

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

De Novo Mutation in DEPDC5 Associated with Unilateral Pachygyria and Intractable Epilepsy

SETD1B Variants Associated with Absence Seizures

Mutation Pattern and Genotype-Phenotype Correlations of SETD2 in Neurodevelopmental Disorders

Whole-exome sequencing identifies a novel de novo mutation in DYNC1H1 in epileptic encephalopathies

Mental retardation, seizures and language delay caused by new SETD1B mutations: Three case reports

SCN8A mutations in Chinese patients with early onset epileptic encephalopathy and benign infantile seizures

Gene Mutation Analysis In 253 Chinese Children With Unexplained Epilepsy And Intellectual/Developmental Disabilities

Mutations of schizophrenia risk gene SETD1A dysregulate synaptic function in human neurons

Genetic analysis of developmental and epileptic encephalopathy caused by novel biallelic SZT2 gene mutations in three Chinese Han infants: a case series and literature review

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

CSMD1 is a causative gene of developmental and epileptic encephalopathy and generalized epilepsies

A De Novo SCN8A Heterozygous Mutation in a Child with Epileptic Encephalopathy: a Case Report.

Novel Loss-of-Function Variants in CHD2 Cause Childhood-Onset Epileptic Encephalopathy in Chinese Patients

Novel and de novo mutations in pediatric refractory epilepsy

Novel variants of SYNGAP1 associated epileptic encephalopathy: two cases report and literature review

Large De Novo Microdeletion in Epilepsy with Intellectual and Developmental Disabilities, with a Systems Biology Analysis.

Germline De Novo Variants in CSNK2B in Chinese Patients with Epilepsy.

De novo variants in KCNJ3 are associated with early-onset epilepsy

Altered Inhibitory Synapses in De Novo GABRA5 and GABRA1 Mutations Associated with Early Onset Epileptic Encephalopathies.